Alembic Pharmaceuticals announced on Monday that it has received approval from the US Food & Drug Administration (USFDA) to market a generic version of Betamethasone Valerate Foam, a medication used to treat moderate-to-severe psoriasis of the scalp.
Alkermes plc has commenced the Vibrance-2 study, which is a phase 2 clinical trial assessing the safety and effectiveness of ALKS 2680 versus placebo in adult patients with narcolepsy type 2 (NT2). ALKS 2680 is a new, under investigation, oral...
Sun Pharmaceutical Industries Limited introduced tedizolid phosphate tablets 200 mg in India with the brand name "Starizo". Starizo (tedizolid phosphate) is a new antibiotic in the oxazolidinone class, prescribed for acute bacterial skin and skin...
Alkem Laboratories has become the first Indian pharmaceutical company to venture into medical devices, following a partnership with US-based Exactech to produce and market its joint replacement implants in India. Through this agreement, Exactech, ...
Pristyn Care, a top player in follow-up surgeries in India, has launched the Innovation Lab, a specialized program aiming to foster progress in AI in the healthcare industry. It will offer AI startups in their early stages a special opportunity...
Adar Poonawalla, CEO of Serum Institute of India (SII), has announced that the company is working on developing a vaccine for Mpox, with expectations of a "positive outcome" within a year. This development comes in response to the global Mpox outb...
Titan Pharmaceuticals, Inc. has revealed that it is engaged in a Merger and Contribution and Share Exchange Agreement for a business merger with KE Sdn. Berhad. The board of directors of Titan approved the Merger Agreement. If Titan's and KE's...
A new scheme aimed at bolstering the domestic medical device industry will be launched within the next month, according to Arunish Chawla, Secretary of the Department of Pharmaceuticals. The scheme is currently being finalized following extensive ...
Granules India's subsidiary, Granules Pharmaceuticals Inc, has been granted approval by the US health regulator for a generic Glycopyrrolate oral solution meant for pediatric patients with neurological conditions linked to drooling. Granules India...
Gilead Sciences has collaborated with PANTHERx Rare to provide LIVDELZI, a medication aimed at adults suffering from primary biliary cholangitis (PBC). The goal of the partnership is to offer patients the specific peroxisome proliferator-activated...
, CDSCO.jpg)
